In Ayurvedic texts vatashthila [i.e.; benign prostatic hyperplasia (BPH)] is a one of major urinary disorder described in mutraghata (i.e.; decreased urine flow due to obstructionin passage). It very common problem geriatric age group males (usually 60-70 years age). Histo-pathologically the prevalence BPH dependent, initiate usually after 40 age. More than 50% men their 60s and upto 90% 70s 80...

prostatic intra-epithelial neoplasia (pin) is considered a precursor of invasive carcinoma, characterized by proliferation and anaplasia of cells lining prostatic ducts and acini. in this study, we applied the pin grading system on one-hundred cases of prostatic carcinoma and one-hundred cases of benign prostatic hyperplasia, then compared the results. 74% of prostatic carcinoma and 51 % of pro...

Holmium laser enucleation of the prostate (HoLEP) surgery has been increasingly used in urology because its advantages for benign prostatic hyperplasia (BPH) surgical treatment recent years. But, there are insufficient data literature about true frequency incidental presence adenoma within bladder following HoLEP surgery. The case is here presented a patient who underwent 5 years previously, th...

Clinical benign prostatic hyperplasia (BPH), often identified as a worsening ability of a male to pass urine, is a significant problem for men in our society. In 2015, the use of personalised medicine is tailoring treatment to individual patient needs and to genetic characteristics. Technological advances in surgical treatment are changing the way BPH is treated and are resulting in less morbid...

This was an open clinical trial undertaken in 25 elderly male patients in the age group of 45-90 years diagnosed with Benign Prostatic Hyperplasia (BPH) in the Department of Shalya Shalakya, Sir Sundarlal Hospital, Institute of Medical Sciences, Banaras Hindu University, Varanasi. Himplasia was administered at a dose of 2 tablets, twice daily for a period of 3 months. All the patients were foll...

BACKGROUND Benign prostatic hyperplasia (BPH) is a common disease of the aging male population. BPH treatment includes a variety of pharmacological and surgical interventions. The goal of this paper is to review the natural history of BPH, outcomes of pharmacological management, effects on quality of life (QoL), future pharmacotherapies, and associated patient-focused perspectives. MATERIALS ...

CONTEXT Prostate cancer (PCa) is the most common cancer in the adult male, and benign prostatic hyperplasia (BPH) represents the most frequent urologic diagnosis in elderly males. Recent data suggest that prostatic inflammation is involved in the pathogenesis and progression of both conditions. OBJECTIVE This review aims to evaluate the available evidence on the role of prostatic inflammation...

Prostatic intra-epithelial neoplasia (PIN) is considered a precursor of invasive carcinoma, characterized by proliferation and anaplasia of cells lining prostatic ducts and acini. In this study, we applied the PIN grading system on one-hundred cases of prostatic carcinoma and one-hundred cases of benign prostatic hyperplasia, then compared the results. 74% of prostatic carcinoma and 51 % of...

Introduction: Estrogen Receptor 1 (ESR1) expression has appeared to impact prostate cancer advancement significantly. This study aims compare the of ESR-1 in BPH and cancer. Methods: The samples were collected from a single-center hospital 2014 2020. We exclude which RNA concentration is under minimum standard allowance proceed. Deparaffinize formalin-fixed paraffin-embedded RNAs extraction by ...

OBJECTIVE To evaluate the usefulness of phytotherapy in the treatment of the benign prostatic hyperplasia (BPH) and prostatic adenocarcinoma (ADCP). ACQUISITION OF EVIDENCE Systematic review of the evidence published until January 2011 using the following scientific terms: phytotherapy, benign prostate hyperplasia, prostatic adenocarcinoma, prostate cancer and the scientific names of compound...